{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T03:58:19Z","timestamp":1773201499354,"version":"3.50.1"},"reference-count":38,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1097\/md.0000000000005861","type":"journal-article","created":{"date-parts":[[2017,1,18]],"date-time":"2017-01-18T05:40:22Z","timestamp":1484718022000},"page":"e5861","source":"Crossref","is-referenced-by-count":14,"title":["Efficacy and safety of bisphosphonates in management of low bone density in inflammatory bowel disease"],"prefix":"10.1097","volume":"96","author":[{"given":"Liwei","family":"Yao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haiqing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenwei","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenxin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haijiao","family":"Mao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-17-20210309","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nature10209","article-title":"Genetics and pathogenesis of inflammatory bowel disease","volume":"474","author":"Khor","year":"2011","journal-title":"Nature"},{"key":"R2-17-20210309","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1053\/gast.2003.50106","article-title":"AGA technical review on osteoporosis in gastrointestinal diseases","volume":"124","author":"Bernstein","year":"2003","journal-title":"Gastroenterology"},{"key":"R3-17-20210309","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1111\/j.1572-0241.1999.01079.x","article-title":"Evolution of osteopenia in inflammatory bowel disease","volume":"94","author":"Dinca","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"R4-17-20210309","doi-asserted-by":"crossref","first-page":"795","DOI":"10.7326\/0003-4819-133-10-200011210-00012","article-title":"The incidence of fracture among patients with inflammatory bowel disease. A population-based cohort study","volume":"133","author":"Bernstein","year":"2000","journal-title":"Ann Intern Med"},{"key":"R5-17-20210309","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1136\/gut.51.5.654","article-title":"High prevalence of osteoporotic vertebral fractures in patients with Crohn's disease","volume":"51","author":"Klaus","year":"2002","journal-title":"Gut"},{"key":"R6-17-20210309","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1359\/jbmr.2000.15.6.993","article-title":"Use of oral corticosteroids and risk of fractures","volume":"15","author":"Van Staa","year":"2000","journal-title":"J Bone Miner Res"},{"key":"R7-17-20210309","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1097\/00042737-200308000-00004","article-title":"The pathophysiology of bone disease in gastrointestinal disease","volume":"15","author":"Bernstein","year":"2003","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R8-17-20210309","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1097\/00042737-200311000-00003","article-title":"Effect of systemic glucocorticoid therapy on bone metabolism and the osteoprotegerin system in patients with active Crohn's disease","volume":"15","author":"von","year":"2003","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R9-17-20210309","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1136\/gut.2005.064212","article-title":"Influence of IL-6, COL1A1, and VDR gene polymorphisms on bone mineral density in Crohn's disease","volume":"54","author":"Todhunter","year":"2005","journal-title":"Gut"},{"key":"R10-17-20210309","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/MOG.0000000000000037","article-title":"Risk factors and management of osteoporosis in inflammatory bowel disease","volume":"30","author":"Targownik","year":"2014","journal-title":"Curr Opin Gastroenterol"},{"key":"R11-17-20210309","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/ibd.20541","article-title":"Body mass and composition affect bone density in recently diagnosed inflammatory bowel disease: the Manitoba IBD Cohort Study","volume":"15","author":"Leslie","year":"2009","journal-title":"Inflamm Bowel Dis"},{"key":"R12-17-20210309","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1136\/gut.52.1.63","article-title":"Osteoporosis in inflammatory bowel disease","volume":"52","author":"Compston","year":"2003","journal-title":"Gut"},{"key":"R13-17-20210309","doi-asserted-by":"crossref","first-page":"367","DOI":"10.3109\/00365529609006412","article-title":"Smoking is a risk factor for osteoporosis in women with inflammatory bowel disease","volume":"31","author":"Silvennoinen","year":"1996","journal-title":"Scand J Gastroenterol"},{"key":"R14-17-20210309","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.3109\/09513590.2013.813468","article-title":"Systematic review and meta-analysis of the efficacy and safety of alendronate and zoledronate for the treatment of postmenopausal osteoporosis","volume":"29","author":"Serrano","year":"2013","journal-title":"Gynecol Endocrinol"},{"key":"R15-17-20210309","doi-asserted-by":"crossref","first-page":"340","DOI":"10.3904\/kjim.2011.26.3.340","article-title":"Efficacy and safety of monthly 150\u200amg oral ibandronate in women with postmenopausal osteoporosis: a systematic review and meta-analysis of randomized controlled trials","volume":"26","author":"Lee","year":"2011","journal-title":"Korean J Intern Med"},{"key":"R16-17-20210309","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1517\/14656566.8.16.2743","article-title":"Effects of antifracture drugs in postmenopausal, male and glucocorticoid-induced osteoporosis\u2014usefulness of alendronate and risedronate","volume":"8","author":"Iwamoto","year":"2007","journal-title":"Expert Opin Pharmacother"},{"key":"R17-17-20210309","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0140-6736(88)92721-3","article-title":"Prevention of steroid-induced osteoporosis with (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD)","volume":"1","author":"Reid","year":"1988","journal-title":"Lancet"},{"key":"R18-17-20210309","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/jor.21229","article-title":"Effects of estrogen deficiency and bisphosphonate therapy on osteocyte viability and microdamage accumulation in an ovine model of osteoporosis","volume":"29","author":"Brennan","year":"2011","journal-title":"J Orthop Res"},{"key":"R19-17-20210309","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1001\/jama.2014.14038","article-title":"Bisphosphonate prescriptions in men with androgen deprivation therapy use","volume":"312","author":"Gulamhusein","year":"2014","journal-title":"JAMA"},{"key":"R20-17-20210309","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1007\/s12020-014-0506-5","article-title":"Bisphosphonates in the treatment of glucocorticoid-induced osteoporosis: pros","volume":"49","author":"Rossini","year":"2015","journal-title":"Endocrine"},{"key":"R21-17-20210309","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/S0197-2456(99)00026-4","article-title":"Assessing the quality of randomized trials: reliability of the Jadad scale","volume":"20","author":"Clark","year":"1999","journal-title":"Control Clin Trials"},{"key":"R22-17-20210309","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1053\/gast.2000.16518","article-title":"Alendronate increases lumbar spine bone mineral density in patients with Crohn's disease","volume":"119","author":"Haderslev","year":"2000","journal-title":"Gastroenterology"},{"key":"R23-17-20210309","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1111\/j.1365-2036.2003.01794.x","article-title":"A randomized controlled trial of calcium with vitamin D, alone or in combination with intravenous pamidronate, for the treatment of low bone mineral density associated with Crohn's disease","volume":"18","author":"Bartram","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"R24-17-20210309","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1046\/j.1365-2036.2003.01448.x","article-title":"Therapy of osteoporosis in patients with Crohn's disease: a randomized study comparing sodium fluoride and ibandronate","volume":"17","author":"von","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"R25-17-20210309","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1007\/s00198-005-1927-z","article-title":"Efficacy of risedronate administration in osteoporotic postmenopausal women affected by inflammatory bowel disease","volume":"16","author":"Palomba","year":"2005","journal-title":"Osteoporos Int"},{"key":"R26-17-20210309","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S1542-3565(04)00663-9","article-title":"Randomized trial of etidronate plus calcium and vitamin D for treatment of low bone mineral density in Crohn's disease","volume":"3","author":"Siffledeen","year":"2005","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R27-17-20210309","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1572-0241.2006.00372.x","article-title":"A double-blind placebo-controlled study of the effects of the bisphosphonate risedronate on bone mass in patients with inflammatory bowel disease","volume":"101","author":"Henderson","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"R28-17-20210309","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/j.cgh.2007.05.016","article-title":"A double-blind placebo-controlled study of intravenous clodronate for prevention of steroid-induced bone loss in inflammatory bowel disease","volume":"5","author":"Abitbol","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R29-17-20210309","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/j.1365-2036.2008.03899.x","article-title":"Clinical trial: comparison of alendronate and alfacalcidol in glucocorticoid-associated osteoporosis in patients with ulcerative colitis","volume":"29","author":"Kitazaki","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"key":"R30-17-20210309","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s00198-009-0960-8","article-title":"Use of risedronate to prevent bone loss following a single course of glucocorticoids: findings from a proof-of-concept study in inflammatory bowel disease","volume":"21","author":"Kriel","year":"2010","journal-title":"Osteoporos Int"},{"key":"R31-17-20210309","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1111\/j.1442-200X.2010.03174.x","article-title":"Zoledronic acid for the treatment of osteopenia in pediatric Crohn's disease","volume":"52","author":"Sbrocchi","year":"2010","journal-title":"Pediatr Int"},{"key":"R32-17-20210309","doi-asserted-by":"crossref","first-page":"334","DOI":"10.3748\/wjg.v17.i3.334","article-title":"Bones and Crohn's: no benefit of adding sodium fluoride or ibandronate to calcium and vitamin D","volume":"17","author":"Klaus","year":"2011","journal-title":"World J Gastroenterol"},{"key":"R33-17-20210309","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.crohns.2012.01.004","article-title":"Risedronate improves bone mineral density in Crohn's disease: a two year randomized controlled clinical trial","volume":"6","author":"Soo","year":"2012","journal-title":"J Crohns Colitis"},{"key":"R34-17-20210309","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1136\/gutjnl-2013-305523","article-title":"Treatment of bone loss in osteopenic patients with Crohn's disease: a double-blind, randomised trial of oral risedronate 35\u200amg once weekly or placebo, concomitant with calcium and vitamin D supplementation","volume":"63","author":"van Bodegraven","year":"2014","journal-title":"Gut"},{"key":"R35-17-20210309","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.maturitas.2013.09.009","article-title":"Inflammatory bowel disease and the risk of osteoporosis and fracture","volume":"76","author":"Targownik","year":"2013","journal-title":"Maturitas"},{"key":"R36-17-20210309","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1007\/s10620-012-2465-0","article-title":"The efficacy and safety of bisphosphonates for osteoporosis or osteopenia in Crohn's disease: a meta-analysis","volume":"58","author":"Guo","year":"2013","journal-title":"Dig Dis Sci"},{"key":"R37-17-20210309","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.cgh.2012.10.022","article-title":"Inflammatory bowel disease has a small effect on bone mineral density and risk for osteoporosis","volume":"11","author":"Targownik","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R38-17-20210309","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.cgh.2013.08.024","article-title":"Efficacy and safety of medical therapy for low bone mineral density in patients with inflammatory bowel disease: a meta-analysis and systematic review","volume":"12","author":"Melek","year":"2014","journal-title":"Clin Gastroenterol Hepatol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000005861","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:41:48Z","timestamp":1620960108000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201701200-00017"}},"subtitle":["A meta-analysis"],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000005861","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]}}}